Continuing the race adjustment factors maintains health care disparities, the authors noted.
Clinicians should stop using the race adjustment factor in pulmonary function testing (PFT), according to a recent entry in the Things We Do for No Reason series in the Journal of Hospital Medicine.
The authors wrote that adjusting spirometry values stems from old studies about differences in lung function among races, which were then applied to testing. As a result, lung volume reference values for Black patients are 10% to 15% lower than values for White patients.
There are 3 reasons why the race adjustment factor in PFT is injurious to patients, the authors wrote:
“The medical community should follow the lead of other equations, like estimated glomerular filtration rate and the vaginal birth after cesarean calculator, which have successfully removed race factors,” the authors wrote.
Continuing race adjustment maintains health care disparities, they said, and any concerns about the possibility of overdiagnosing disease must be outweighed by the harm that comes from underdiagnosing it.
They called upon clinicians to:
“As a profession, we must practice race-conscious medicine that values individualized care, recognizes the contributions of structural racism and social determinants in patient health, and standardize care when possible, based on objective metrics,” they wrote.
The Things We Do for No Reason series is inspired by the Choosing Wisely program, which seeks to promote high-value care by educating clinicians and the public about low-value care.
Reference
Beaverson S, Ngo VM, Pahuja M, Dow A, Nana-Sinkham P, Schefft M. Things We Do for No Reason: race adjustments in calculating lung function from spirometry measurements. J Hosp Med. Published online October 7, 2022. 10.1002/jhm.12974
Collaborative Care Model Offers Success in Reducing Suicide Risk, New Report Finds
April 10th 2025A report published today by the American Foundation for Suicide Prevention underscores the potential of the collaborative care model to lower suicide risk across diverse patient populations and health systems.
Read More
NCCN Data Find Racial, Socioeconomic Disparities in Quality of Care for Metastatic Pancreatic Cancer
April 9th 2025New data from the National Comprehensive Cancer Network (NCCN) reveal that socially vulnerable and minority patients with metastatic pancreatic cancer are less likely to receive recommended treatments and achieve longer survival.
Read More
Lp(a) and Getting a Head Start Against Heart Disease: Jeremy Wigginton, MD
April 8th 2025Lipoprotein a (Lp[a]) is a valuable tool for assessing a patient's risk of cardiovascular disease, which can facilitate earlier intervention efforts and reduce health care costs, argued Jeremy Wigginton, MD.
Read More
Collaborative Care Model Offers Success in Reducing Suicide Risk, New Report Finds
April 10th 2025A report published today by the American Foundation for Suicide Prevention underscores the potential of the collaborative care model to lower suicide risk across diverse patient populations and health systems.
Read More
NCCN Data Find Racial, Socioeconomic Disparities in Quality of Care for Metastatic Pancreatic Cancer
April 9th 2025New data from the National Comprehensive Cancer Network (NCCN) reveal that socially vulnerable and minority patients with metastatic pancreatic cancer are less likely to receive recommended treatments and achieve longer survival.
Read More
Lp(a) and Getting a Head Start Against Heart Disease: Jeremy Wigginton, MD
April 8th 2025Lipoprotein a (Lp[a]) is a valuable tool for assessing a patient's risk of cardiovascular disease, which can facilitate earlier intervention efforts and reduce health care costs, argued Jeremy Wigginton, MD.
Read More
2 Commerce Drive
Cranbury, NJ 08512